The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.
The supposedly reformed drug warrior's intransigence on the issue complicates his appeal to young voters, who overwhelmingly favor legalization.
Under the Controlled Substances Act, the agency does not have the discretion to "deschedule marijuana altogether."
The points about marijuana's risks and benefits that the department now concedes were clear long before last August.
Just as there are adult reasons for vape companies to sell flavored vape pods, there are adult reasons for drug dealers to color their fentanyl.
Research is promising, but drug warriors stand in the way.
The founder of MAPS talks about FDA approval for MDMA-assisted therapy and the "psychedelic renaissance" he has helped create.
The 1988 case highlighted the DEA's stubborn insistence that marijuana has no "accepted medical use."
Although the HHS-recommended change would benefit researchers and the cannabis industry, it would not resolve the conflict between state and federal marijuana laws.
Plus: Tennessee prosecutor threatens to use drag law that was declared unconstitutional, ACLU asks FTC to investigate Mastercard's adult content policy, and more...
While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.
For five decades, the agency has destroyed countless lives while targeting Americans for personal choices and peaceful transactions.
Plus: Senate Republicans spar over TikTok and free speech, Americans can't agree on how to cut spending, and more...
On Friday, the DEA unveiled a plan to restrict doctors' ability to prescribe controlled drugs over telehealth.
It is hard to find evidence of this "disturbing trend."
Thousands of local, state, and federal law-enforcers have access to sensitive financial data.
A Law That Facilitates Cannabis Research Exemplifies the Modesty of the Reforms We Can Expect From Congress
Making it easier for scientists to study marijuana is a far cry from the liberalization that most Americans want.
"Keep safe from COVID by following CDC advice to wear a mask."
"I'm skeptical that [dealers] would try to target children where there is not an existing market," says Sally Satel.
Plus: FIRE sues to stop the Stop WOKE Act, processing times for skilled immigrants skyrocket, and more...
SCOTUS Rules That Doctors Who Write Prescriptions in Good Faith Can't Be Convicted of Drug Trafficking
The unanimous decision will rein in prosecutions that have long had a chilling effect on pain treatment.
Several Justices Seem Dismayed at the Idea That Doctors Can Be Accidentally Guilty of Drug Trafficking
The Supreme Court is considering what standard should apply to prescribers accused of violating the Controlled Substances Act.
Patients suffer when physicians who prescribe opioids in good faith can face decades in prison.
It should not matter whether would-be ayahuasca drinkers sincerely believe in shamanism or simply believe they will derive mental health benefits from the experience.
Despite civil asset forfeiture reforms in Florida, police are still finding ways to take people's stuff.
A drug that treats opioid addiction may also be abused. That’s not a good reason to restrict access.
Keddins Etienne's experience shows that bullies who seize innocent people's property tend to back down when their victims put up a fight.
Federal prosecutors agreed to drop a civil asset forfeiture case against Kermit Warren's $28,000 in cash, which he said he was trying to buy a tow truck with.
In the DEA's view, the fact that most states allow patients to use marijuana for symptom relief is irrelevant.
The case is the latest example of people who say their savings were seized in airports, despite it being perfectly legal to fly domestically with large amounts of cash.
Plus: 88,000 New Jersey marijuana cases dismissed, Slate looks inside the conservative publishing industry, and more...
The 9th Circuit Considers Whether the DEA's Classification of Marijuana Violates Federalism and the Separation of Powers
The puzzle of marijuana's Schedule I status invites a reconsideration of the agency's vast discretion to decide which substances should be prohibited.
A Twitter Tiff Between Former Federal Health Officials Highlights the Weakness of the Case for Banning Kratom
Former Assistant Secretary for Health Brett Giroir says former FDA Commissioner Scott Gottlieb's support for a ban was based on "embarrassingly poor evidence."
In 2014, Reason reported on the misbehavior of Rod Ponton, who has suddenly risen to internet stardom after being unable to turn off an adorable filter during an online legal case.
After the DEA Robbed Her of $43,000 at an Airport, She Joined a Class Action Challenging the Agency's Cash Grabs
The lawsuit argues that the DEA is violating the Fourth Amendment by seizing money from travelers without evidence of criminal activity.
A Formerly Secret Memo Explains the DEA's Long Delay in Approving New Producers of Marijuana for Research
The Justice Department concluded in 2018 that an anti-drug treaty requires stricter controls than the DEA originally planned.
A class-action lawsuit is now challenging the DEA's habit of seizing large amounts of cash from travelers without evidence of any crime.
CTPharma's collaboration with Yale researchers seems to be the first clinical trial involving U.S.-grown marijuana that is not supplied by the federal government.